UBS Reaffirms Buy on NVIDIA, $185 Price Target

Mar 17, 2025 Analyst: Timothy Arcuri 1 min read Reproduced verbatim
Rating
Buy
Price target
$185
Implied upside
+52%
vs $121.67 prior close
UBS and NVIDIA logos

UBS analyst Timothy Arcuri reiterated a Buy rating and $185 price target on NVIDIA (NASDAQ: NVDA)’

“We did hear about slightly less aggressive expansion plans for TSMC for CoWoS capacity by YE25/YE26 (70k/110k v prior 80k/120k) but we think this is largely due to improving CoWoS-L yields rather than any demand signal, and our full year projection for NVDA GPU shipments remains essentially unchanged at ~6.1MM units, though the mix is now slightly more skewed to B300/GB300 than our prior model.”

Also, “Following our modifications to mix, we are now at ~$46B in revenue for FQ1 (April) and $5.27/$6.22 EPS for C2025E/2026E.

Uncertainly around AI Diffusion will likely remain high, but we remain bullish with the stock still trading <20x our C2026E EPS.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+89% NVDA $121.67 → $230.48 (Oct 9) · target reached

This call✓ Target reached on Sep 30, 2025, 8 months after the note. Same target as this firm’s Jan 27, 2025 note, so it is scored there.

Firm track recordUBS: 72% of its 18 targets at least a year old were reached within 12 months (#14 of 20 firms); on NVIDIA, 5 of 5. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.